Citi Pharma posts flat 9MFY25 profit at nearly Rs680m

MG News | April 30, 2025 at 04:46 PM GMT+05:00
April 30, 2025 (MLN): Citi Pharma Ltd. (PSX: CPHL) reported a net profit of Rs678.84 million for the nine months ended March 31, 2025, nearly unchanged from Rs681.40m in SPLY, reflecting a flat performance despite a decline in pre-tax earnings.
Earnings per share stood at Rs2.97, slightly down from Rs2.98 a year ago.
The company’s net sales rose 6% to Rs10.10 billion from Rs9.54bn, driven by increased demand and operational scale.
Cost of sales grew proportionately by 6% to Rs8.64bn, keeping gross profit growth at 8%, amounting to Rs1.46bn.
However, operating profit also rose 8% to Rs1.17bn despite higher selling expenses, which surged 19% to Rs119.70m.
Citi Pharma’s financial cost increased 15% to Rs231.51m, while other income sharply declined by 47% to Rs165.82m, reducing support to the bottom line. As a result, profit before income taxes and final tax fell by 8% to Rs1.03bn.
Taxation decreased by 20% year-on-year to Rs349.84m, helping offset some of the pressure on net profit.
Condensed interim statement of profit and loss for the nine month ended 31 March 2025 (in Rupees) | 2025 | 2024 | %Change |
Sales - Net | 10,100,185,059 | 9,535,266,706 | 6% |
Cost of Sales | (8,643,865,934) | (8,192,103,683) | 6% |
Gross Profit | 1,456,319,125 | 1,343,163,023 | 8% |
Administrative Expenses | 161,904,092 | 154,757,727 | 5% |
Selling Expenses | 119,703,970 | 100,497,146 | 19% |
Operating Profit | 1,174,711,063 | 1,087,908,150 | 8% |
Financial (Cost) / Income | (231,505,104) | (200,800,962) | 15% |
Other Income/(Loss) | 165,818,206 | 312,952,864 | -47% |
Other Expenses | (80,335,099) | (82,062,737) | -2% |
Profit before income taxes and final tax | 1,028,689,066 | 1,117,997,315 | -8% |
Taxation - Final taxes | (4,004) | (255,970) | -98% |
Profit before income tax | 1,028,685,062 | 1,117,741,345 | -8% |
Taxation - Income tax | (349,842,286) | (436,344,074) | -20% |
Profit after income tax | 678,842,776 | 681,397,271 | 0% |
Earnings per share (EPS) - Basic and Diluted | 2.97 | 2.98 |
Copyright Mettis Link News
Related News
Name | Price/Vol | %Chg/NChg |
---|---|---|
KSE100 | 163,806.22 500.44M | -0.39% -638.50 |
ALLSHR | 99,845.79 1,977.49M | -0.42% -417.42 |
KSE30 | 50,123.85 153.24M | -0.68% -343.31 |
KMI30 | 238,530.50 71.49M | -0.36% -850.63 |
KMIALLSHR | 65,898.10 543.80M | -0.37% -245.35 |
BKTi | 46,380.96 92.15M | -0.49% -229.01 |
OGTi | 31,857.40 12.33M | -1.20% -387.93 |
Symbol | Bid/Ask | High/Low |
---|
Name | Last | High/Low | Chg/%Chg |
---|---|---|---|
BITCOIN FUTURES | 108,950.00 | 109,605.00 107,690.00 | 2275.00 2.13% |
BRENT CRUDE | 61.10 | 61.55 60.88 | -0.19 -0.31% |
RICHARDS BAY COAL MONTHLY | 80.50 | 0.00 0.00 | -1.00 -1.23% |
ROTTERDAM COAL MONTHLY | 93.20 | 93.50 93.20 | 0.05 0.05% |
USD RBD PALM OLEIN | 1,085.00 | 1,085.00 1,085.00 | 0.00 0.00% |
CRUDE OIL - WTI | 56.98 | 57.43 56.76 | -0.17 -0.30% |
SUGAR #11 WORLD | 15.53 | 15.88 15.45 | -0.27 -1.71% |
Chart of the Day
Latest News
Top 5 things to watch in this week
Pakistan Stock Movers
Name | Last | Chg/%Chg |
---|
Name | Last | Chg/%Chg |
---|